Sign In
Buy RANI
$0.633
-0.0546 (-7.95%)
At Close: Jul 13, 2026
Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
03:49pm, Friday, 30'th Jul 2021
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI), a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq in its initial public offering. Rani Shares Trade Around IPO Price: R
Rani Therapeutics Announces Pricing of Initial Public Offering
08:56am, Friday, 30'th Jul 2021
SAN JOSE, Calif., July 30, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”), a clinical stage biotherapeutics company focused on advancing technologies
